IONIS-PKK-LRx

Ionis unveils positive PhII data for in-house rare disease drug, paving way to blockbuster rivalry with Takeda
Endpoints
Mon, 03/29/21 - 10:52 pm
Ionis Pharmaceuticals
clinical trials
IONIS-PKK-LRx
hereditary angiodema